Skip to main content
spacbrain

Disc Medicine

Closed (deSPAC)

Health Care · hematologic disease therapeutics

What it is
Medicine, Inc
What it’s doing now
Merging with FS Development Corp. (FSDC) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.

The business, per its filings

SEC primary

Medicine, Inc. Disc Medicine is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. Disc is building a portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. For more information, please visit www.discmedicine.com.

Source: S-4/A, accession 0001140361-22-043943

What the company says about itself

Web research — not audited

Disc Medicine is a biopharmaceutical company harnessing breakthrough science to advance hematology care, focusing on turning scientific discoveries into effective medicines for hematologic diseases.

Markets:
Hematology
Products:
Bitopertin | DISC-0974 | DISC-3405
What our web check found

[WEB-INTEL 2026-08-26] 2 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "expected to have approximately $175 million of cash or cash equivalents" [https://ir.discmedicine.com/news-releases/news-release-details/gemini-therapeutics-and-disc-medicine-announce-merger-agreement] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "approximately $175 million of cash" [https://www.nasdaq.com/press-release/disc-medicine-announces-completion-of-merger-with-gemini-therapeutics-2022-12-29]

Source: https://www.discmedicine.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Disc Medicine is merging with FS Development Corp. (FSDC) currently marked Closed (deSPAC).

Headline equity value—

Structure per SEC accession(s) 0001140361-22-032239. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Disc Medicine going public?

Disc Medicine has an approved merger with the SPAC FS Development Corp. (FSDC). Deal status: Closed (deSPAC).

Does Disc Medicine have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals
Same sponsor’s other SPACs
  • FSII — FS Development Corp. II · Closed (deSPAC)